INVESTMENT PORTFOLIO
Structured Private Equity
We seek to invest with entrepreneurs, general partners, and sponsors who have successfully built or accumulated assets with demonstrable, but illiquid, value and either (a) have opportunities to invest as principals in their own high conviction ideas but lack the liquidity to do so, or (b) seek to realize liquidity against illiquid assets.
In our typical structured private equity transaction, we provide the capital needed to fund an opportunity and secure our investment via unrelated assets that our partner is willing to subordinate in exchange for retaining a larger equity upside in our investment.
Our agreements typically feature “convexity” by employing escalating cost incentives for early redemption by our partners. In many circumstances, we invest alongside a partner who shares our investing philosophy and plays an active role in managing the investment. We favor self-liquidating investments and opportunities in which we have the ability to recapture principal rapidly while participating in future value creation.
● We offer superior economics vs raising equity, allowing the entrepreneur to retain the majority of a transaction’s upside.
● We are more flexible than debt: typically non-recourse, with no fixed maturity, and no prepayment penalties.
● We have broad and robust experience with a wide range of alternative collateral assets that traditional lenders can’t easily underwrite.
● We are an attractive alternative to a secondary sale of the principal’s personal stake.
● We are aligned with the entrepreneur to seek rapid principal repayment to minimize cost but have no fixed horizon to determine outcomes.
● We do not seek to influence operations of the assets unless we have not been repaid.
Leveraged Buy Outs
We target control acquisitions involving companies within commercial, industrial, and professional services, as well as those in healthcare services and value-added manufacturing.
-
$10 million to $30 million of equity per transaction
-
Revenues over $10 million and EBITDA over $2 million
-
Enterprise value between $10 million and $100 million
-
Growth Equity
We target companies exhibiting high organic growth rates coupled with an established and scalable business model.
-
$2-$10MM check size paired with at least one (1) board seat
-
Cyclades looks to add operational value and support on top of a capital investment to scale operations
-
Industries include healthcare, light manufacturing, enterprise software, and consumer
-
Leveraged Buy Outs
We target control acquisitions involving companies within commercial, industrial, and professional services, as well as those in healthcare services and value-added manufacturing.
-
$10 million to $30 million of equity per transaction
-
Revenues over $10 million and EBITDA over $2 million
-
Enterprise value between $10 million and $100 million
Growth Equity
We target companies exhibiting high organic growth rates coupled with an established and scalable business model.
-
$2-$10MM check size paired with at least one (1) board seat
-
Cyclades looks to add operational value and support on top of a capital investment to scale operations
-
Industries include healthcare, light manufacturing, enterprise software, and consumer
Special Situation Financiers
Leveraged Buy Outs
We target control acquisitions involving companies within commercial, industrial, and professional services, as well as those in healthcare services and value-added manufacturing.
-
$10 million to $30 million of equity per transaction
-
Revenues over $10 million and EBITDA over $2 million
-
Enterprise value between $10 million and $100 million
Growth Equity
We target companies exhibiting high organic growth rates coupled with an established and scalable business model.
-
$2-$10MM check size paired with at least one (1) board seat
-
Cyclades looks to add operational value and support on top of a capital investment to scale operations
-
Industries include healthcare, light manufacturing, enterprise software, and consumer
Leveraged Buy Outs
Industries we target: Commercial, Industrial & Professional Services, Healthcare Services, Value-added manufacturing.
Growth Equity
We target companies exhibiting high organic growth rates coupled with an established and scalable business model.
$10 million to $30 million of equity per transaction
Revenues over $10 million and EBITDA over $2 million
Enterprise value between $10 million and $100 million
$2 - $10MM check size paired with at least one (1) board seat.
Cyclades looks to add operational value and support on top of a capital investment to scale operations.
Industries include healthcare, light manufacturing, enterprise software, and consumer.